Surges in circulating interleukin-6 and transforming growth factor-β associated with exercise in patients with COPD are attenuated by pulmonary rehabilitation Source: Annual Congress 2009 - Exploring outcome measures in COPD and pulmonary rehabilitation Year: 2009
Serum levels of vascular endothelial growth factor in patients with active pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 341s Year: 2006
Serum levels of vascular endothelial growth factor in the differential diagnosis of pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002
Association of elevated CRP and IL-6 with rapid decline in lung function and exacerbation in tuberculosis destroyed lung Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
Serum levels of vascular endothelial growth factor (VEGF) are elevated in patients with acute exacerbated COPD Source: Eur Respir J 2005; 26: Suppl. 49, 350s Year: 2005
Increased levels of vascular endothelial growth factor in induced sputum in asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002
Vascular endothelial growth factor (VEGF) levels in induced sputum and plasma in asymptomatic and COPD smokers. Correlation with airway and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007
Serum leptin and tumor necrosis factor – alpha levels and maximal exercise performance in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008
Increased levels of epidermal growth factor in sputum of smoking chronic bronchitis patients Source: Eur Respir J 2003; 22: Suppl. 45, 178s Year: 2003
Low plasma stem cell factor combined with high transforming growth factor-a identifies high-risk patients in pulmonary arterial hypertension Source: ERJ Open Res, 4 (4) 00035-2018; 10.1183/23120541.00035-2018 Year: 2018
An indicative role of serum transforming growth factor-beta 1 (TGF-β1) level on the determination of clinical severity of pulmonary tuberculosis Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005
Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001
Serum levels of vascular endothelial growth factor in lung cancer patients Source: Eur Respir J 2004; 24: Suppl. 48, 77s Year: 2004
Vascular endothelial growth factor levels in active pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 610s Year: 2002
Transforming growth factor (TGF)-b1 gene common polymorphisms and plasma TGF-b1 levels in patients with lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 435s Year: 2005
Comparison of the serum soluble IL-2 receptor levels in the differential diagnosis of pulmonary tuberculosis and lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001
Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001
Plasma stromal derived factor 1 alpha levels in pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 141s Year: 2006
High serum periostin levels and the association with pulmonary tuberculosis Source: International Congress 2018 – Diagnosis of tuberculosis Year: 2018